Aemetis (AMTX) and Its Competitors Head-To-Head Review

Aemetis (NASDAQ: AMTX) is one of 25 public companies in the “Industrial organic chemicals” industry, but how does it compare to its peers? We will compare Aemetis to related companies based on the strength of its earnings, valuation, dividends, institutional ownership, profitability, risk and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and target prices for Aemetis and its peers, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aemetis 0 2 1 0 2.33
Aemetis Competitors 120 479 744 26 2.49

Aemetis presently has a consensus price target of $2.00, suggesting a potential upside of 17.32%. As a group, “Industrial organic chemicals” companies have a potential upside of 10.76%. Given Aemetis’ higher possible upside, analysts clearly believe Aemetis is more favorable than its peers.

Valuation and Earnings

This table compares Aemetis and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Aemetis $150.15 million -$30.30 million -1.92
Aemetis Competitors $3.36 billion $346.13 million 4.24

Aemetis’ peers have higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

15.9% of Aemetis shares are owned by institutional investors. Comparatively, 52.8% of shares of all “Industrial organic chemicals” companies are owned by institutional investors. 24.2% of Aemetis shares are owned by insiders. Comparatively, 14.2% of shares of all “Industrial organic chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.


This table compares Aemetis and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aemetis -20.19% N/A -36.85%
Aemetis Competitors -11.48% -11.19% -5.31%

Risk & Volatility

Aemetis has a beta of -0.67, suggesting that its stock price is 167% less volatile than the S&P 500. Comparatively, Aemetis’ peers have a beta of 0.49, suggesting that their average stock price is 51% less volatile than the S&P 500.


Aemetis peers beat Aemetis on 9 of the 12 factors compared.

About Aemetis

Aemetis, Inc. operates as an international renewable fuels and bio-chemicals company in North America and India. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries. The company owns and operates a biodiesel plant in Kakinada, India; and an ethanol plant in Keyes, California. Aemetis, Inc. sells biodiesel and glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit